Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils

The combination of immunotherapy with platinum-based chemotherapy has become the first-line treatment for patients with advanced non–small cell lung cancer (NSCLC) with negative driver gene mutations. However, finding an ideal chemotherapeutic regimen for immunotherapy and exploring the underlying m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ziwei, Zhao, Yiming, Chen, Si, Cui, Guohui, Fu, Wenkui, Li, Shouying, Lin, Xiaorong, Hu, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240830/
https://www.ncbi.nlm.nih.gov/pubmed/35784745
http://dx.doi.org/10.3389/fphar.2022.870178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240830/
https://www.ncbi.nlm.nih.gov/pubmed/35784745
http://dx.doi.org/10.3389/fphar.2022.870178

Ejemplares similares